Shanghai Serum Bio-technology Co., Ltd. Class ASSE: 688163

"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Sep 29, 2026 · Issued by Shanghai Serum Bio-technology Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Shanghai Serum Bio-technology Co., Ltd. Class A

"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Voluntary Disclosure of Receipt of the Certificate of GMP Compliance from the PhilippinesSep 25
"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Departure of a Director, Senior Management Member and Core Technical Personnel, By-election of a Director and Adjustment of Core Technical PersonnelSep 12
"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Implementation of Dividend Distribution for the First Half of 2026Sep 9
"SHANGHAI SERUM BIO-TECHNOLOGY CO., LTD."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO IndustrySep 4

All Shanghai Serum Bio-technology Co., Ltd. Class A news releases